Texas Instruments today, opened the door for developers to implement high-performing DLP display technology with virtually any low-cost processor. The new 0.2-inch DLP2000 chipset and $99 DLP® LightCrafter™ Display 2000 evaluation module (EVM) now make it more affordable to leverage DLP technology and design on-demand, free-form display applications such as mobile smart TVs; pico projectors; digital signage; projection displays for smart homes, smartphones and tablets; and control panels and Internet of Things (IoT) display solutions. For more information about the DLP2000, see https://www.ti.com/DLP2000-pr-eu.
With the DLP LightCrafter Display 2000 EVM, developers worldwide can easily design with DLP technology. The EVM’s dual connector is set up to support any flexible GPIO-driven video interface capable of up to 24-bit red/green/blue (RGB)-capable processor, including the BeagleBone Black development board based on TI Sitara™ AM335x processors, and includes software drivers and BeagleBone Black code examples for easy programming. This makes the technology more accessible for developers to incorporate high-performing DLP Pico™ displays into new applications.
Key features and benefits of the DLP2000 chipset and EVM
Availability and pricing
The DLP2000 is available now for US$19.99 and the DLP LightCrafter Display 2000 EVM is available for US$99.00 through the TI store and authorized distributors. For more information, see www.ti.com/dlp2000 or watch the DLP LightCrafter Display 2000 demo to see how quickly you can get started.
Open and Secure Synopsys Autopilot Platform Accelerates Engineering Productivity, Improves Design Quality, and Achieves Faster…
Acquisition brings leading AI model research expertise to AMD, helping to shape future AI infrastructure…
Following its merger with Bank Leumi USA, the expansion of its activities with technology companies…
Infineon and Eaton are partnering to drive solid-state transformer (SST) technology The collaboration addresses demand…
The future of work belongs to people and AI agents. Island built the control plane…
Financing builds on FDA clearances, growing clinical evidence and commercial traction to advance the UltraSight…